- Home
- ORGO vs FPI Comparison
ORGO vs FPI Comparison
Compare ORGO & FPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- FPI
- Stock Information
- Founded
- ORGO 1985
- FPI 2013
- Country
- ORGO United States
- FPI United States
- Employees
- ORGO N/A
- FPI N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- FPI Real Estate Investment Trusts
- Sector
- ORGO Health Care
- FPI Real Estate
- Exchange
- ORGO Nasdaq
- FPI Nasdaq
- Market Cap
- ORGO 465.6M
- FPI 516.0M
- IPO Year
- ORGO N/A
- FPI 2014
- Fundamental
- Price
- ORGO $4.51
- FPI $10.60
- Analyst Decision
- ORGO Buy
- FPI
- Analyst Count
- ORGO 2
- FPI 0
- Target Price
- ORGO $6.50
- FPI N/A
- AVG Volume (30 Days)
- ORGO 895.4K
- FPI 471.4K
- Earning Date
- ORGO 08-07-2025
- FPI 07-23-2025
- Dividend Yield
- ORGO N/A
- FPI 2.26%
- EPS Growth
- ORGO N/A
- FPI 229.01
- EPS
- ORGO N/A
- FPI 1.21
- Revenue
- ORGO $458,760,000.00
- FPI $55,000,000.00
- Revenue This Year
- ORGO $3.50
- FPI N/A
- Revenue Next Year
- ORGO $8.59
- FPI N/A
- P/E Ratio
- ORGO N/A
- FPI $8.80
- Revenue Growth
- ORGO 5.35
- FPI N/A
- 52 Week Low
- ORGO $2.28
- FPI $9.66
- 52 Week High
- ORGO $6.71
- FPI $12.87
- Technical
- Relative Strength Index (RSI)
- ORGO 53.20
- FPI 37.32
- Support Level
- ORGO $4.67
- FPI $10.44
- Resistance Level
- ORGO $5.15
- FPI $10.85
- Average True Range (ATR)
- ORGO 0.28
- FPI 0.27
- MACD
- ORGO -0.04
- FPI -0.09
- Stochastic Oscillator
- ORGO 53.70
- FPI 14.71
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About FPI Farmland Partners Inc.
Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.